Rebekka Fendt, Ahmed Ghallab, Maiju Myllys, Ute Hofmann, Reham Hassan, Zaynab Hobloss, Daniela González, Lisa Brackhagen, Rosemarie Marchan, Karolina Edlund, Abdel-Latif Seddek, Noha Abdelmageed, Lars M Blank, Jan-Frederik Schlender, Christian H Holland, Jan G Hengstler, Lars Kuepfer
Rationale: Liver cirrhosis is known to affect drug pharmacokinetics, but the functional assessment of the underlying pathophysiological alterations in drug metabolism is difficult. Methods: Cirrhosis in mice was induced by repeated treatment with carbon tetrachloride for 12 months. A cocktail of six drugs was administered, and parent compounds as well as phase I and II metabolites were quantified in blood, bile, and urine in a time-dependent manner. Pharmacokinetics were modeled in relation to the altered expression of metabolizing enzymes...
2023: Frontiers in Pharmacology